Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (161-170 of 466) with videos related to

Pageof 47
Sort By:
Journal of Hepatology|May 11, 2006
Cancer incidence in people with hepatitis B or C infection: a large community-based linkage studyJanaki Amin, Gregory J Dore, Dianne L O'Connell, et al.
Expert Review of Molecular Diagnostics|January 4, 2024
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?Jason Grebely, Susan Matthews, Louise M Causer, et al.
The International Journal on Drug Policy|October 29, 2025
Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep studyChloe Montague, Rugiatu Bah, Yumi Sheehan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design ConsiderationsJordan J Feld, Julie Bruneau, Gregory J Dore, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 1, 2006
The effect of hepatitis C virus infection on health-related quality of life in prisonersHla-Hla Thein, Tony Butler, Murray Krahn, et al.
Journal of Gastroenterology and Hepatology|May 28, 2011
Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or CScott R Walter, Hla-Hla Thein, Heather F Gidding, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 22, 2012
Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohortHla-Hla Thein, Scott R Walter, Heather F Gidding, et al.
Journal of Hepatology|March 24, 2009
Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screeningMonica C Robotin, Melanie Kansil, Kirsten Howard, et al.
Open Forum Infectious Diseases|July 16, 2016
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionMarianne Martinello, Gregory J Dore, Jasmine Skurowski, et al.
The International Journal on Drug Policy|February 21, 2015
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, AustraliaCarla Treloar, Jake Rance, Nicky Bath, et al.
Pageof 47

Showing results (161-170 of 466) with videos related to

Sort By:
Pageof 47
Journal of Hepatology|May 11, 2006
Cancer incidence in people with hepatitis B or C infection: a large community-based linkage studyJanaki Amin, Gregory J Dore, Dianne L O'Connell, et al.
Expert Review of Molecular Diagnostics|January 4, 2024
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?Jason Grebely, Susan Matthews, Louise M Causer, et al.
The International Journal on Drug Policy|October 29, 2025
Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep studyChloe Montague, Rugiatu Bah, Yumi Sheehan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design ConsiderationsJordan J Feld, Julie Bruneau, Gregory J Dore, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 1, 2006
The effect of hepatitis C virus infection on health-related quality of life in prisonersHla-Hla Thein, Tony Butler, Murray Krahn, et al.
Journal of Gastroenterology and Hepatology|May 28, 2011
Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or CScott R Walter, Hla-Hla Thein, Heather F Gidding, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 22, 2012
Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohortHla-Hla Thein, Scott R Walter, Heather F Gidding, et al.
Journal of Hepatology|March 24, 2009
Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screeningMonica C Robotin, Melanie Kansil, Kirsten Howard, et al.
Open Forum Infectious Diseases|July 16, 2016
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionMarianne Martinello, Gregory J Dore, Jasmine Skurowski, et al.
The International Journal on Drug Policy|February 21, 2015
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, AustraliaCarla Treloar, Jake Rance, Nicky Bath, et al.
Pageof 47